Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Mounting evidence shows that Alzheimer's disease (AD) manifests the dysfunction of the brain network much earlier before the onset of clinical symptoms, making its early diagnosis possible. Current brain network analyses treat high-dimensional network data as a regular matrix or vector, which destroys the essential network topology, thereby seriously affecting diagnosis accuracy. In this context, ...
Analysis of functional connectivity networks (FCNs) derived from resting-state functional magnetic resonance imaging (rs-fMRI) has greatly advanced our understanding of brain diseases, including Alzheimer's disease (AD) and attention deficit hyperactivity disorder (ADHD). Advanced machine learning techniques, such as convolutional neural networks (CNNs), have been used to learn high-level feature ...
BACKGROUND: Dementia rates are rising globally, impacting healthcare systems and society. The care of people with dementia is largely provided by info...
BACKGROUND: New or worsening cognitive impairment or dementia is common in older adults following an episode of critical illness, and screening post-d...
In neuroscience, phase synchronization (PS) is a crucial mechanism that facilitates information processing and transmission between different brain re...
Alzheimer's disease is the most common cause of dementia in the elderly population (aged 65 years and over), followed by vascular dementia, Lewy body ...
: Caregivers experience high rates of occupational injuries, especially during wheelchair transfers, which often result in back pain and musculoskelet...
The application of deep learning techniques to analyze brain functional magnetic resonance imaging (fMRI) data has led to significant advancements in ...
Alzheimer's disease (AD), a prevalent neurodegenerative disorder, leads to progressive dementia, which impairs decision-making, problem-solving, and c...
OBJECTIVE: Blood DNA methylation (DNAm) alterations have been widely reported in the onset and progression of mild cognitive impairment (MCI) and Alzh...
BACKGROUND: Alzheimer's disease (AD) is strongly associated with slowly progressive hippocampal atrophy. Elucidating the relationships between local m...
OBJECTIVE: To apply machine learning approaches on EEG event-related oscillations (ERO) to discriminate preclinical Alzheimer's disease (AD) from age-...
BACKGROUND: Alzheimer's disease (AD) and vascular dementia (VaD) share overlapping pathophysiological characteristics, yet comparative genetic studies...
Understanding the morphology of amyloid fibrils is crucial for comprehending the aggregation and degradation mechanisms of abnormal proteins implicate...
Multimodal neuroimaging data, including magnetic resonance imaging (MRI) and positron emission tomography (PET), provides complementary information ab...
OBJECTIVE: Dementia is a significant medical and social issue in most developed countries. Practical tools for predicting the progression of degenerat...
The detection of patients in the cognitive normal (CN), mild cognitive impairment (MCI), and Alzheimer's disease (AD) stages of neurodegeneration is c...
The clinical spectrum of Alzheimer's disease (AD) ranges dynamically from asymptomatic and mild cognitive impairment (MCI) to mild, moderate, or sever...
BACKGROUND: Although digital technology represents a growing field aiming to revolutionize early Alzheimer disease risk prediction and monitoring, the...
Machine learning has gained attention in the medical field. Continuous efforts are being made to develop robust models for early prognosis purposes. T...